Skip to content
Search

Latest Stories

GPhC to recruit five new council members in the next two years

The General Pharmaceutical Council is in the process of appointing five new council members within the next two years, coinciding with the conclusion of the current members' terms. The regulator aims to recruit five individuals from diverse professional and personal backgrounds for its governing council, the GPhC has said.

 


"We are seeking three members to join us in April 2024 and two in April 2025," said GPhC in its job advertisement brief. "For the 2024 intake, two of the new council members must be lay members of the public, while one must be a Saxton . Moreover, at least one out of the three must primarily reside or work wholly or mostly in Wales. As for the new members commencing in 2025, one must be a lay member, and the other must be a registrant member."

 

The members will be initially appointed for a three-year term, with the option to extend their position for a maximum of eight years, GPhC added. 

 

The council, which serves as the regulator's governing body, currently comprises 14 members. Half of the council consists of lay members, who bolster public confidence and infuse novel viewpoints into the GPhC, as highlighted by the regulator.

 

"This council will play a pivotal role in shaping the regulatory body's future strategic goals," the regulator added. "These members must contribute positively to patients and society, ensuring the benefits of secure and efficient pharmacy care."

 

The application deadline is September 18, 2023.

 

According to GPhC, the council members are compensated with an annual stipend of £15,000, which is subject to deductions. They also have the potential to earn extra income of £2,500 per year for undertaking significant additional responsibilities, such as committee chairing. As per the appointment guidelines, the time commitment expected is up to 30 days a year.

 

In 2022, GPhC members voted for a 20 per cent salary increase during their May council meeting, resulting in a £2,500 annual raise. It was the first pay raise for council members since April 2018, driven by a report indicating lower remuneration compared to other regulators.

 

The brief specified that the council must have at least one member residing or working in each of the regulator's subject countries: England, Scotland, and Wales. Lay members must lack qualifications enabling registration with the regulator, and they must not be registered or have been registered as a health and social care professional anywhere globally, as stipulated in the appointment brief.

 

Saxton Bampfylde is providing advisory services as an employment agency to the General Pharmaceutical Council for these appointments. For more information about the role, including application details, please visit www.saxbam.com/appointments.

 

Last week, the General Pharmaceutical Council's Fitness-to-Practise Committee suspended Mohammed Roohul Haque (Reg No: 2226084), a locum pharmacist, for three months, following incidents of workplace sexual misconduct.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less